1.1. Articles de périodiques
- Avolio C. et al. Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-ß.
Brain Research Bulletin, 2003, n° 61, p. 357-364. ISSN 0361-9230.
- Bellomi Francesca et al. Fate of neutralizing and binding antibodies to IFN ß in MS patients treated with IFN ß for 6 years.
Journal of the Neurological Sciences, avril 2003, n° 215, p. 3-8. ISSN 0022-510X.
- Bergh F. et al. Impact of type-I-interferon on monocyte subsets and their differentiation to dentric cells: an in vivo and
ex vivo study in multiple sclerosis patients treated with interferon-ß. Journal of Neuroimmunology, octobre 2003, n° 146,
p. 176-188. ISSN 0165-5728.
- Chofflon Michel et Ben-Amorb Ali-Frederic. Long-term benefits of early and high doses of interferon ß -1a treatment in
relapsing-remitting multiple sclerosis. Clinical Neurology and Neurosurgery, juillet 2002, n° 104, p. 244-248. ISSN 0303-8467.
- Christopher B. et Heller Renu A. Gene microarray analysis of multiple sclerosis lesions. Trends in Molecular Medicine,
décembre 2003, n° 9, p. 535-541. ISSN 1471-4914.
- Croxford J. Ludovic et Miller Stephen D. Immunoregulation of a viral model of multiple sclerosis using the synthetic
cannabinoid R(+)WIN55,212. The Journal of Clinical Investigation, février 2003, n° 111, p. 1231-1240. ISSN 0021-9738.
- Evans C. F. et Shriver L. P. Multiple sclerosis Emerging Opportunities for Therapeutic. Current Drug Targets CNS
Neurological Disorder, février 2002, n°1, vol 1, p. 17-30.
- Goodin D. S., Frohman E. M. et al. Disease modifying therapies in multiple sclerosis. Neurology, 2002, n° 58, p. 169-178.
ISSN 0028-3878.
- Grigoriadis Nikolaos. Interferon treatment in relapsing-remitting multiple sclerosis - A review. Clinical Neurology and
Neurosurgery, juillet 2002, n° 104, p. 251-258. ISSN 0303-8467.
- Hartrich Laura et al. Dynamics of immune cell trafficking in interferon-ß treated multiple sclerosis patients. Journal
of Neuroimmunology, avril 2003, n° 139, pages 84-92. ISSN 0165-5728.
- Ossege L. M., Sindern E. et al. Immunomodulatory effects of interferon-ß-1b in patients with multiple sclerosis.
International Immunopharmacology, juin 2001, n° 1, p. 1085-1100. ISSN 1567-5769.
- Polman Chris H. et Uitdehaag Bernard M. J. New and emerging treatment options for multiple sclerosis. The Lancet
Neurology, septembre 2003, n° 2, p. 563-566. ISSN 1474-4422.
- Revel Michel. Interferon-ß in the treatment of relapsing-remitting multiple sclerosis. Pharmacology & Therapeutics,
octobre 2003, n° 100, p. 49-62. ISSN 0163-7258.
- Smith Begolka Wendy, Vanderlugt Carol L. et al. Differential Expression of Inflammatory Cytokines Parallels.
The Journal of Immunology, octobre 1998, n° 161, vol 8, p. 4437-4446. ISSN 0022-1767.
- Tajouri Lotti, Mellicka Albert S. et al. Quantitative and qualitative changes in gene expression patterns
characterize the activity of plaques in multiple sclerosis. Molecular Brain Research, novembre 2003, n° 119, p.
170-183. ISSN 0169-328X.
1.2. Articles en ligne
- Greenstein Jeffrey I. Problems in Clinical Trial Design in Multiple Sclerosis. International Journal of MS Care,
automne 2002, n° 4 [consulté le 14 novembre 2003] 3 p. [en ligne].
[http://www.mscare.com/a0210/page_03.htm]
- Kaufman Michael. Combining Therapies with Interferon ? for Relapsing and Early Progressive MS: A Review.
International Journal of MS Care, juin 2002, n° 4 [consulté le 14 novembre 2003] 1 p. [en ligne].
[http://www.mscare.com/a0206/page_01.htm]
- Wee Yong V. Pathology, Immunology, and Neuroprotection in MS Mechanisms and Influence of MS Therapeutics. International
Journal of MS Care, décembre 2002, supplément [consulté le 23 mars 2004] 2 p. [en ligne].
[http://www.mscare.org/journal/s0212/page_02.cfm]
1.3. Sites Internet
- Anonyme. National MS Society. New-York, The National Multiple Sclerosis Society, 1995, mise à jour 2004 [consulté le 23
juin 2004]. [http://www.nationalmssociety.org/]
1.4. Documents en ligne
|
